BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 13996899)

  • 1. [A SIMPLE METHOD FOR DETERMINING THE LEVEL OF FIBRINOGEN AND FIBRINOLYTIC ACTIVITY)].
    GORSHKOVA TN; LOMAZOVA KhD
    Lab Delo; 1965; 3():167-9. PubMed ID: 14297069
    [No Abstract]   [Full Text] [Related]  

  • 2. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 3. EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT.
    WINCKELMANN G; HIEMEYER V
    Scand J Clin Lab Invest; 1964; 16():SUPPL 79:7-14. PubMed ID: 14199708
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current possibility of thrombolytic treatment].
    VERSTRAETE M; AMERY A
    Brux Med; 1962 Dec; 42():1437-54. PubMed ID: 13996898
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS.
    HELLE I; AAS K; GODAL HC
    Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607
    [No Abstract]   [Full Text] [Related]  

  • 6. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and pathological studies: thrombolytic activity and related phenomena.
    VERSTRAETE M
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():328-9. PubMed ID: 13996899
    [No Abstract]   [Full Text] [Related]  

  • 8. [SALIVA AND BLOOD COAGULATION].
    SCHULTE W
    Dtsch Zahnarztl Z; 1964 Mar; 19():193-201. PubMed ID: 14140027
    [No Abstract]   [Full Text] [Related]  

  • 9. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PATHOLOGICAL FIBRINOLYSIS.
    SHARP AA
    Br Med Bull; 1964 Sep; 20():240-6. PubMed ID: 14216086
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytics. 46].
    Wagler M
    Pharm Prax; 1970; 6():141-2. PubMed ID: 4195438
    [No Abstract]   [Full Text] [Related]  

  • 12. The signficance of fibrinolysis. The significance of the fibrinolytic mechanism.
    Sharp AA
    Proc R Soc Lond B Biol Sci; 1969 Jul; 173(1032):311-5. PubMed ID: 4389505
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.